| Q48721287 | A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program |
| Q33792991 | A splicing variant of NME1 negatively regulates NF-κB signaling and inhibits cancer metastasis by interacting with IKKβ |
| Q39199734 | AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKL. |
| Q39328413 | Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a |
| Q36914091 | Acute myeloid leukaemia: optimal management and recent developments |
| Q37888960 | Applications of post-translational modifications of FoxO family proteins in biological functions |
| Q26781364 | Caenorhabditis elegans DAF-16/FOXO transcription factor and its mammalian homologs associate with age-related disease |
| Q89983202 | Chlorzoxazone, a small molecule drug, augments immunosuppressive capacity of mesenchymal stem cells via modulation of FOXO3 phosphorylation |
| Q29617418 | Crosstalk in NF-κB signaling pathways |
| Q46887116 | Decitabine-Induced Changes in Human Myelodysplastic Syndrome Cell Line SKM-1 Are Mediated by FOXO3A Activation. |
| Q41377055 | FOXO Signaling Pathways as Therapeutic Targets in Cancer |
| Q38674456 | FOXO transcription factors in cancer development and therapy |
| Q26853741 | FOXO transcription factors throughout T cell biology |
| Q34221760 | FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma. |
| Q46443231 | FOXO3 Transcription Factor Is Essential for Protecting Hematopoietic Stem and Progenitor Cells from Oxidative DNA Damage |
| Q90226885 | FOXO3a from the Nucleus to the Mitochondria: A Round Trip in Cellular Stress Response |
| Q50137602 | FoxO transcription factors in cancer metabolism |
| Q35318592 | Hypothalamic inflammation: a double-edged sword to nutritional diseases |
| Q34730816 | IKBKE phosphorylation and inhibition of FOXO3a: a mechanism of IKBKE oncogenic function |
| Q35857192 | Inflammatory cause of metabolic syndrome via brain stress and NF-κB. |
| Q39062437 | Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML. |
| Q30427503 | Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression |
| Q34442297 | Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation |
| Q37173070 | NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance. |
| Q33675855 | PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells. |
| Q35474548 | Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrix |
| Q35810507 | Pelle Modulates dFoxO-Mediated Cell Death in Drosophila |
| Q50057271 | Regulation of FOXO Factors in Mammalian Cells. |
| Q37995693 | Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer |
| Q37865381 | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. |
| Q39590044 | Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. |
| Q34173253 | Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway |
| Q37440267 | The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells |
| Q35001723 | The IκB kinase complex in NF-κB regulation and beyond |
| Q37837732 | Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways. |
| Q101564352 | Therapeutic strategies targeting FOXO transcription factors |
| Q92090915 | Tyrosine nitrations impaired intracellular trafficking of FSHR to the cell surface and FSH-induced Akt-FoxO3a signaling in human granulosa cells |
| Q35781570 | miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway |